Atlas Trials

Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer

Clinical trial NCT05981001 · RECRUITING

Trial details

NCT number
NCT05981001
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Breast Neoplasms
Start date
2023-08-01
Primary completion
2032-04-30
Enrollment
170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.